TrialBritish journal of cancer2017

Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.

Richard Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.